PHSI-BRG
PHSI-BRG
Home
Staff
Sarah Al Ashmori
Andy Bryant
Thomas Chadwick
Svetlana Cherlin
Mike Cole
Holly Fisher
Tony Fouweather
Shaun Hiu
Dorcas Kareithi
Ann Breeze Konkoth
Nan Lin
Jingky Lozano-Kuehne
Helen Mossop
Ellen Moss
Aritra Mukherjee
Jérémie Nsengimana
Vicky Ryan
Marzieh Shahmandi
Moha Shojaei
Dawn Teare
James Wason
Faye Williamson
Nina Wilson
Sylvia Zhang
PhD students
Ruqayya Azher
Nicole Cizauskas
Laura Etfer
Niamh Fitzgerald
Raiann Hamshaw
Pela Okorie
Samuel Sarkodie
Lou Whitehead
Methodology research
Overview
Adaptive designs
Master protocols
Transforming IMID trials
Projects
Publications
News
Courses
Adaptive Designs and Multiple Testing Procedures
Leveraging External Information
Precision Medicine Clinical Trials
Contact
Light
Dark
Automatic
2
The role of comorbidities alongside patient and disease characteristics on long-term disease activity in RA using UK inception cohort data
Genes regulated by DNA methylation are involved in distinct phenotypes during melanoma progression and are prognostic factors for patients
Optimised point estimators for multi-stage single-arm phase II oncology trials
Cost-utility analysis of LEGO based therapy for school children and young people with autism spectrum disorder: results from a randomised controlled trial
Determining the OPTIMAL DTI analysis method for application in cerebral small vessel disease
Improving power in PSA response analyses of metastatic castration-resistant prostate cancer trials
Response adaptive intervention allocation in stepped-wedge cluster randomized trials
Generalisations of a Bayesian decision-theoretic randomisation procedure and the impact of delayed responses
The use of DIY (do it yourself) sampling and telemonitoring model for COVID-19 qPCR testing scale up
*PLoS ONE* 2021; 16(11):e0259398
Advantages of multi-arm non-randomised sequentially allocated cohort designs for Phase II oncology trials
«
»
Cite
×